These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 9100613

  • 1. Growth hormone therapy in GH-deficient adults: the problem of the dose.
    Amato G, Bellastella A.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1304-6. PubMed ID: 9100613
    [No Abstract] [Full Text] [Related]

  • 2. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults.
    Hartleb S, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Pfützner A, Kann PH, German KIMS Board, German KIMS Pharmacogenetics Study Group.
    Pharmacogenomics; 2011 Dec; 12(12):1653-61. PubMed ID: 22026923
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS, Australasian Paediatric Endocrine Group (APEG).
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency.
    Yuen KC, Cook DM, Rumbaugh EE, Cook MB, Dunger DB.
    Horm Res; 2006 Jul; 65(1):6-13. PubMed ID: 16340214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acromegaly induced by growth hormone replacement therapy.
    Karges B, Pfäffle R, Boehm BO, Karges W.
    Horm Res; 2004 Jul; 61(4):165-9. PubMed ID: 14707471
    [Abstract] [Full Text] [Related]

  • 11. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
    Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P, Wüster C.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
    [Abstract] [Full Text] [Related]

  • 12. Changes in body composition during 12 months after discontinuation of growth hormone therapy in young adults with growth hormone deficiency from childhood.
    Stouthart PJ, de Ridder CM, Rekers-Mombarg LT, van der Waal HA.
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():335-8. PubMed ID: 10698598
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference.
    Soares DV, Conceição FL, Brasil RR, Spina LD, Lobo PM, Silva EM, Buescu A, Vaisman M.
    Growth Horm IGF Res; 2004 Dec; 14(6):436-41. PubMed ID: 15519251
    [Abstract] [Full Text] [Related]

  • 14. Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adults.
    Burt MG, Gibney J, Hoffman DM, Umpleby AM, Ho KK.
    Growth Horm IGF Res; 2008 Feb; 18(1):55-64. PubMed ID: 17714967
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The syndrome of growth hormone deficiency in adults: current criteria for the diagnosis and treatment].
    Díez JJ.
    Med Clin (Barc); 2000 Apr 01; 114(12):468-77. PubMed ID: 10846703
    [No Abstract] [Full Text] [Related]

  • 17. Impact of GH substitution on exercise capacity and muscle strength in GH-deficient adults: a meta-analysis of blinded, placebo-controlled trials.
    Rubeck KZ, Bertelsen S, Vestergaard P, Jørgensen JO.
    Clin Endocrinol (Oxf); 2009 Dec 01; 71(6):860-6. PubMed ID: 19508603
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
    Janssen YJ, Hamdy NA, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1998 Jun 01; 83(6):2143-8. PubMed ID: 9626153
    [Abstract] [Full Text] [Related]

  • 20. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
    Lucidi P, Lauteri M, Laureti S, Celleno R, Santoni S, Volpi E, Angeletti G, Santeusanio F, De Feo P.
    J Clin Endocrinol Metab; 1998 Feb 01; 83(2):353-7. PubMed ID: 9467540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.